Piramal Pharma Ltd

NSE: PPLPHARMA · BSE: 543635 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹206.59
Market cap: ₹27,504 Cr
Revenue (annual): ₹8,869 Cr
Net profit (annual): ₹-325.9 Cr
P/E (TTM): -87.7×Sector 49.7×
Promoter holding: 34.80%-0.06% QoQ
FII holding: 12.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 4 Other Announcement 3 Share Pledge 2 Merger & Restructuring 2 Annual General Meeting 2 Results Update 1 Regulatory Approval 1 Financial Results 1 Employee Stock Options 1 Earnings Call 1 Board Meeting Date 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Jul 2026 10:53 IST BSE

Regulatory Approval

Piramal Pharma Regulatory Approval

Piramal Pharma disclosed that the US FDA has successfully completed its inspection of the Sellersville manufacturing facility. The clearance affirms compliance and operational continuity.

Read the filing ↗